Alloxan: history and mechanism of action

Diabetologia: Clinical and Experimental Diabetes and Metabolism

Volumn 31, Issue 6, 1988, Pages 337-342

  Lenzen, S ^a   Panten, U ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; GLUCOKINASE;

ALLOXAN DIABETES MELLITUS; BOOK; DIABETES MELLITUS; ISLET; NONBIOLOGICAL MODEL; NONHUMAN; PANCREAS;

ALLOXAN; ANIMAL; DIABETES MELLITUS, EXPERIMENTAL; GLUCOKINASE; ISLETS OF LANGERHANS; SUPPORT, NON-U.S. GOV'T;

EID: 0023748601     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF02341500     Document Type: Review

References (87)

1. Untersuchungen zur Natur der Harnsäure
2. Briefwechsel zwischen
3. Alloxan and dialuric acid: their stabilities and ultraviolet absorption spectra
4. Alloxan
5. Necrosis of islets of Langerhans produced experimentally
6. Hypoglycemic action of alloxan
7. The production of diabetes mellitus in rabbits with alloxan
8. Alloxan
9. Experimental alloxan diabetes in the rat
10. Alloxan diabetes mellitus in the dog
11. Production of diabetes mellitus in rats with alloxan
12. Necrosis of the islets of Langerhans produced experimentally
13. The diabetogenic effect of alloxan after elimination of extra-pancreatic factors
14. Further observations on the effects of alloxan on the pancreatic islets
15. The pathology of the pancreas in experimental diabetes mellitus
16. Alloxan diabetes. Its production and mechanism
17. Alloxandiabetes
18. Alloxan diabetes
19. Zur Histophysiologie des Inselapparates
20. Factors controlling the development and progression of diabetes
21. Action of sulphur compounds on carbohydrate metabolism and on diabetes
22. Experimental diabetes research in fish
23. Functional characterization and metabolic pathways of the pancreatic islets tissue
24. Drugs producing diabetes through damage of the insulin secreting cells
25. Der experimentelle chemische Diabetes
26. Action of toxic drugs on islet cells
27. Alloxan toxicity to the pancreatic B-cell
28. Über den Mechanismus der Oxidationsvorgänge VIII. Zum oxydativen Abbau der Aminosäuren
29. Das Alloxan als Oxydationsmittel für Thiolgruppen, als Kapillargift und als Krampfgift
30. Notiz zur Reaktion der Gewebe mit Alloxan
31. Protective effect of glutathione and cysteine against alloxan diabetes in the rat
32. Further studies of effect of sulphur compounds on production of diabetes with alloxan
33. The mechanism of cysteine and glutathione protection against alloxan diabetes
34. Reversal of the diabetogenic action of alloxan by sulfhydryl compounds
35. Protection against alloxan diabetes by glucose
36. On the protection against alloxan diabetes by hexoses
37. Studies on protection against the diabetogenic effect of alloxan by glucose
38. Signal recognition by pancreatic B-cells
39. Tissue-specific expression of glucokinase: identification of the gene-product in liver and pancreatic islets
40. Glucokinase in pancreatic B-cells and its inhibition by alloxan
41. New perspectives on pancreatic islet glucokinase
42. Inhibition of glucokinase in hepatocytes by alloxan
43. Inhibition of rat liver glucokinase by alloxan and ninhydrin
44. Identification of glucokinase as an alloxan-sensitive glucose sensor of the pancreaticβ-cell
45. Parallel inhibition of islet glucokinase and glucose-stimulated insulin secretion by either alloxan or ninhydrin
46. Competition between alloxan and glucose for the glucokinase sugar binding site
47. Alloxan stimulation and inhibition of insulin release from isolated rat islets of Langerhans
48. Studies on the mechanism of alloxan inhibition of glucose-induced insulin release
49. Mechanism of barbituric-acid protection against inhibition by alloxan of glucoseinduced insulin release
50. Diabetogenic action of alloxan-like compounds: the effect of dehydrouramil hydrate hydrochloride on isolated islets of Langerhans of the rat
51. Beta cell protection to alloxan necrosis by anomers of D-glucose
52. Effect of anomers of D-glucose on alloxan inhibition of insulin release in isolated perifused pancareatic islets
53. Interaction of alloxan and anomers of D-glucose on glucose-induced insulin secretion and biosynthesis in vitro
54. Differential effect of alpha- and beta-D-glucose on protection against alloxan toxicity in isolated islets
55. Effect of alloxan on insulin secretion in isolated rat islets perifused in vitro
56. Glucose and alloxan interactions in the pancreatic islets
57. Studies of alloxan toxicity on the beta cell
58. Anomeric specificity of 3-O-methyl-D-glucopyranose against alloxan diabetes
59. Effects of alloxan on glucose-stimulated insulin secretion, glucose metabolism, and cyclic adenosine 3′, 5′-monophosphate levels in rat isolated islets of Langerhans
60. Alloxan uptake by isolated rat islets of Langerhans
61. Transport systems of islet cells
62. Noncarbohydrate nutrients protect against alloxan-induced inhibition of insulin release
63. Transamination of neutral amino acids and 2-keto acids in the pancreatic B-cell mitochondria
64. Effect of alloxan on arginine- and leucine-in- duced insulin secretion in isolated islets
65. Alloxan-induced alteration of insulin release, rubidium efflux and glucose metabolism in rat islets stimulated by various secretagogues
66. Effect of alloxan on permeability of pancreatic islet tissue in vitro
67. Effect of alloxan on islet tissue permeability: protection and reversal by dithiols
68. Inhibition of enzymatic transphosphorylation by alloxan and ninhydrin in tissue extracts
69. Sensitivity of pancreas hexokinase towards alloxan and its modification by glucose
70. Inhibition of liver hexokinase by dehydroascorbic acid and alloxan
71. 2+- and calmodulin-de- pendent protein kinase activity in pancreatic islets
72. + and adenine nucleotides, membrane potential and volume change in vitro
73. Mechanism of alloxan-induced calcium release from rat liver mitochondria
74. The pyrimidines
75. Sequencing a protein by X-ray crystallography. II. Refinement of yeast hexokinase B co-ordinates and sequence at 2.1 Å resolution
76. A refined model of the sugar binding site of yeast hexokinase B
77. Reaction of rat hepatic glucokinase with substrate-related and other alkylating agents
78. Affinity labelling of rat-muscle hexokinase type II by a glucose-derived alkylating agent
79. High resolution crystal structures of yeast hexokinase complexes with substrates, activators, and inhibitors. Evidence for an allosteric control site
80. Effect of alloxan on permeability and hexose transport in rat pancreatic islets
81. On the mechanism of glucose protection against alloxan toxicity
82. Molecular requirements for recognition at a glucoreceptor for insulin release